Upregulation of proangiogenic factors such as vascular endothelial growth factor (VEGF) and neurotrophic factors via βARs leads to upregulation of matrix metalloproteinases, which in turn promotes tumour growth and facilitates tumour invasion into the extracellular matrix (ECM) (44). The gene discussed is VEGFA; the disease is neoplasm.